Rik Johannes Leonardus van der Lans

Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months

Rik Johannes Leonardus van der Lans, Josje Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen et al. · Allergy · 2023 · 74 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +14

Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making

Josje Otten, Rik Johannes Leonardus van der Lans, Eugenio De Corso et al. · Expert Review of Clinical Immunology · 2023 · 31 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis

Wytske J. Fokkens, Rik Johannes Leonardus van der Lans, Sietze Reitsma · Expert Opinion on Biological Therapy · 2021 · 26 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +10

Complete Remission of Severe Eosinophilic Otitis Media With Dupilumab: A Case Report

Rik Johannes Leonardus van der Lans, Erik van Spronsen, Wytske J. Fokkens et al. · The Laryngoscope · 2021 · 20 citations · Full text

Medicine, Immunology, Otolaryngology +17

Hypereosinophilia during dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps

Paul R. Kemp, Rik Johannes Leonardus van der Lans, Josje Otten et al. · Rhinology Journal · 2023 · 18 citations

Medicine, Immunology, Otolaryngology +12